Neumora Therapeutics

NMRA · NASDAQ

$0.465−$0.005 (−1.06%)TodayMarket closed · Oct 20, 7:54 PM ET

Prev close $0.47

Latest news

Press releaseAug 14, 7:00 AM ETGlobe Newswire
Neumora Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
NewsJul 31, 1:24 PM ETVandana Singh
Why Is BioAge Labs Stock Sinking Friday?
Press releaseJul 27, 7:00 AM ETGlobe Newswire
Neumora Therapeutics Reports Favorable NMRA-215 Toxicology Results with Planned Clinical Advancement in 2026
Press releaseJun 18, 10:05 AM ETBusiness Wire
NMRA Investor Alert: Levi & Korsinsky Investigates Neumora Therapeutics (NMRA) for Potential Securities Fraud
Press releaseJun 17, 9:07 AM ETPRNewswire
NMRA SHAREHOLDER INVESTIGATION: SueWallSt Investigates Neumora Therapeutics for Possible Securities Law Violations
Press releaseJun 16, 4:44 PM ETPRNewswire
Neumora Therapeutics Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Neumora Therapeutics (NMRA)
NewsJun 15, 12:47 PM ETVandana Singh
Penny Stock Neumora Therapeutics Cuts Workforce After Depression Trials Fail
Press releaseJun 15, 12:46 PM ETGlobe Newswire
NMRA INVESTOR ALERT: Holzer & Holzer, LLC Investigation of Neumora Therapeutics, Inc.
NewsJun 15, 12:01 PM ETAvi Kapoor
Crude Oil Tumbles Over 5%; Empire State Manufacturing Index Falls In June
NewsJun 15, 10:08 AM ETAvi Kapoor
Dow Jumps Over 600 Points Following US-Iran Peace Deal
Press releaseJun 15, 8:00 AM ETGlobe Newswire
Neumora Therapeutics Reports Data from Phase 3 KOASTAL Program and Provides Business and Pipeline Update
NewsMay 8, 12:02 PM ET
'Health Officials Close To U.S. Secretary Kennedy Explored Ban Of Some Widely Used Antidepressants' - Reuters Exclusive
Press releaseMay 7, 7:00 AM ETGlobe Newswire
Neumora Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
NewsApr 27, 8:02 AM ETAvi Kapoor
Domino's Posts Downbeat Q1 Results, Joins Real Brokerage And Other Big Stocks Moving Lower In Monday's Pre-Market Session
NewsMar 30, 7:11 AM ET
Earnings Scheduled For March 30, 2026
Press releaseMar 30, 6:53 AM ETGlobe Newswire
Neumora Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Press releaseMar 19, 7:27 PM ETBusiness Wire
NMRA Investors Have Opportunity to Join Neumora Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
NewsFeb 17, 2:32 PM ETVandana Singh
Neumora Therapeutics Stock Jumps, Analyst Sees Upside In Alzheimer's Treatment
NewsJan 7, 10:03 AM ETAvi Kapoor
Monte Rosa Therapeutics, Ventyx Biosciences, United Microelectronics And Other Big Stocks Moving Higher On Wednesday
NewsJan 5, 11:11 AM ETVandana Singh
Neumora's Alzheimer's Agitation Drug Shows Early Promise
Press releaseJan 5, 6:35 AM ETGlobe Newswire
Neumora Therapeutics Highlights 2026 Pipeline Strategy and Anticipated Upcoming Milestones
Press releaseJan 5, 6:30 AM ETGlobe Newswire
Neumora Therapeutics Announces Positive Results from NMRA-511 Phase 1b Signal-Seeking Study in Alzheimer's Disease Agitation
NewsDec 23, 5:16 AM ETAvi Kapoor
Why ZIM Integrated Shipping Services Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
NewsDec 1, 9:01 AM ETAvi Kapoor
This Chevron Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
Press releaseNov 6, 7:00 AM ETGlobe Newswire
Neumora Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
Press releaseOct 27, 7:00 AM ETGlobe Newswire
Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study of M4 Positive Allosteric Modulator NMRA-898
NewsOct 23, 1:07 PM ET
12 Health Care Stocks Moving In Thursday's Intraday Session
NewsSep 16, 10:02 AM ETAvi Kapoor
This Warner Bros. Discovery Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
NewsAug 6, 4:33 AM ET
Earnings Scheduled For August 6, 2025
NewsMay 19, 5:05 PM ET
12 Health Care Stocks Moving In Monday's After-Market Session
Press releaseMay 14, 3:50 PM ETPRNewswire
Kuehn Law Encourages Investors of Neumora Therapeutics, Inc. to Contact Law Firm
Press releaseApr 7, 12:32 PM ETBusiness Wire
NMRA Investors Have Opportunity to Lead Neumora Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Press releaseApr 7, 5:45 AM ETPRNewswire
Neumora Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before April 7, 2025 to Discuss Your Rights - NMRA
Press releaseApr 6, 9:35 AM ETGlobe Newswire
Faruqi & Faruqi Reminds Neumora Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 7, 2025 - NMRA
Press releaseApr 5, 6:20 PM ETPRNewswire
NMRA Deadline in 2 Days: Kessler Topaz Meltzer & Check, LLP Reminds Neumora Therapeutics, Inc. (NMRA) Investors of Filing Deadline in Class Action Lawsuit
Press releaseApr 4, 4:05 PM ETPRNewswire
NMRA Deadline: NMRA Investors with Losses in Excess of $100K Have Opportunity to Lead Neumora Therapeutics, Inc. Securities Lawsuit First Filed by The Firm
Press releaseApr 4, 5:45 AM ETPRNewswire
Levi & Korsinsky Reminds Neumora Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 7, 2025 - NMRA
Press releaseApr 3, 7:10 PM ETPRNewswire
NMRA Investors Have Opportunity to Lead Neumora Therapeutics Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
Press releaseApr 3, 5:45 AM ETPRNewswire
Shareholders of Neumora Therapeutics, Inc. Should Contact The Gross Law Firm Before April 7, 2025 to Discuss Your Rights - NMRA
Press releaseApr 2, 10:45 AM ETGlobe Newswire
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Neumora Therapeutics
Press releaseApr 2, 9:05 AM ETPRNewswire
NMRA Investors Have Final Opportunity to Lead Neumora Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Press releaseApr 1, 5:45 AM ETPRNewswire
Levi & Korsinsky Notifies Neumora Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - NMRA
Press releaseMar 31, 12:43 PM ETPRNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Neumora Therapeutics, Inc of Class Action Lawsuit and Upcoming Deadlines - NMRA
Press releaseMar 31, 12:31 PM ETPRNewswire
CLASS ACTION NOTICE FOR NMRA: Kessler Topaz Meltzer & Check, LLP Reminds Neumora Therapeutics, Inc. Shareholders of Securities Fraud Class Action Lawsuit and Encourages Investors with Losses to Contact the Firm
Press releaseMar 31, 5:45 AM ETPRNewswire
Class Action Filed Against Neumora Therapeutics, Inc. (NMRA) Seeking Recovery for Investors - Contact The Gross Law Firm
Press releaseMar 30, 4:00 PM ETPRNewswire
NMRA Deadline: NMRA Investors Have Opportunity to Lead Neumora Therapeutics, Inc. Securities Lawsuit First Filed by The Firm

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Neumora Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Why Is BioAge Labs Stock Sinking Friday?

Neumora Therapeutics Reports Favorable NMRA-215 Toxicology Results with Planned Clinical Advancement in 2026

NMRA Investor Alert: Levi & Korsinsky Investigates Neumora Therapeutics (NMRA) for Potential Securities Fraud

NMRA SHAREHOLDER INVESTIGATION: SueWallSt Investigates Neumora Therapeutics for Possible Securities Law Violations

Neumora Therapeutics Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Neumora Therapeutics (NMRA)

Penny Stock Neumora Therapeutics Cuts Workforce After Depression Trials Fail

NMRA INVESTOR ALERT: Holzer & Holzer, LLC Investigation of Neumora Therapeutics, Inc.

Crude Oil Tumbles Over 5%; Empire State Manufacturing Index Falls In June

Dow Jumps Over 600 Points Following US-Iran Peace Deal

Neumora Therapeutics Reports Data from Phase 3 KOASTAL Program and Provides Business and Pipeline Update

'Health Officials Close To U.S. Secretary Kennedy Explored Ban Of Some Widely Used Antidepressants' - Reuters Exclusive

Neumora Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update

Domino's Posts Downbeat Q1 Results, Joins Real Brokerage And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Earnings Scheduled For March 30, 2026

Neumora Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

NMRA Investors Have Opportunity to Join Neumora Therapeutics, Inc. Fraud Investigation with the Schall Law Firm

Neumora Therapeutics Stock Jumps, Analyst Sees Upside In Alzheimer's Treatment

Monte Rosa Therapeutics, Ventyx Biosciences, United Microelectronics And Other Big Stocks Moving Higher On Wednesday

Neumora's Alzheimer's Agitation Drug Shows Early Promise

Neumora Therapeutics Highlights 2026 Pipeline Strategy and Anticipated Upcoming Milestones

Neumora Therapeutics Announces Positive Results from NMRA-511 Phase 1b Signal-Seeking Study in Alzheimer's Disease Agitation

Why ZIM Integrated Shipping Services Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket

This Chevron Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday

Neumora Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update

Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study of M4 Positive Allosteric Modulator NMRA-898

12 Health Care Stocks Moving In Thursday's Intraday Session

This Warner Bros. Discovery Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

Earnings Scheduled For August 6, 2025

12 Health Care Stocks Moving In Monday's After-Market Session

Kuehn Law Encourages Investors of Neumora Therapeutics, Inc. to Contact Law Firm

NMRA Investors Have Opportunity to Lead Neumora Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Neumora Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before April 7, 2025 to Discuss Your Rights - NMRA

Faruqi & Faruqi Reminds Neumora Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 7, 2025 - NMRA

NMRA Deadline in 2 Days: Kessler Topaz Meltzer & Check, LLP Reminds Neumora Therapeutics, Inc. (NMRA) Investors of Filing Deadline in Class Action Lawsuit

NMRA Deadline: NMRA Investors with Losses in Excess of $100K Have Opportunity to Lead Neumora Therapeutics, Inc. Securities Lawsuit First Filed by The Firm

Levi & Korsinsky Reminds Neumora Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 7, 2025 - NMRA

NMRA Investors Have Opportunity to Lead Neumora Therapeutics Securities Fraud Lawsuit with Faruqi & Faruqi, LLP

Shareholders of Neumora Therapeutics, Inc. Should Contact The Gross Law Firm Before April 7, 2025 to Discuss Your Rights - NMRA

ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Neumora Therapeutics

NMRA Investors Have Final Opportunity to Lead Neumora Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Levi & Korsinsky Notifies Neumora Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - NMRA

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Neumora Therapeutics, Inc of Class Action Lawsuit and Upcoming Deadlines - NMRA

CLASS ACTION NOTICE FOR NMRA: Kessler Topaz Meltzer & Check, LLP Reminds Neumora Therapeutics, Inc. Shareholders of Securities Fraud Class Action Lawsuit and Encourages Investors with Losses to Contact the Firm

Class Action Filed Against Neumora Therapeutics, Inc. (NMRA) Seeking Recovery for Investors - Contact The Gross Law Firm

NMRA Deadline: NMRA Investors Have Opportunity to Lead Neumora Therapeutics, Inc. Securities Lawsuit First Filed by The Firm